Directions and needs in asbestos research: new insights: conference summary

Our plain-English summary of Directions and needs in asbestos research: new insights: conference summary, by J.C. Pfau, M. Pershouse, E.A. Putnam (Journal of Immunotoxicology, 2008).

The study

• Authors: J.C. Pfau, M. Pershouse, E.A. Putnam
• Journal: Journal of Immunotoxicology
• Published: 2008;5(2):123-7
• Read it: PubMed · Publisher

Abstract

The Center for Environmental Health Sciences (CEHS) Conference, entitled "Directions and Needs in Asbestos Research: New Insights," was held at the University of Montana in Missoula. Researchers, physicians, health care workers, and federal agency representatives from around the country met for a cross-disciplinary exploration of many issues related to asbestos research. Topics included community and psychosocial issues in biomedical research, asbestos exposure assessment, assessment and mechanisms of asbestos related diseases, and new research directions. This meeting report is a summary of the conference presentations, and of the topics identified for future research directions. This conference was a follow-up to one hosted by the CEHS in June 2002, and continued to take advantage of opportunities to work with a unique population in Libby MT, where significant asbestos exposures have occurred due to the mining of asbestos-contaminated vermiculite. The goals of this conference were to bring together experts from diverse fields to identify progress made since the last conference and to develop new research avenues that would allow us to address the research needs in emerging asbestos-exposed populations. Participants indicated that these objectives were met, and expressed enthusiasm for follow-up conferences to maintain the dialog that has been established regarding directions and needs in asbestos research. Selected papers from the conference are presented here.

In plain English

This article was a meeting report, not a research study. The authors summarized a conference called "Directions and Needs in Asbestos Research: New Insights," held at the University of Montana in Missoula. About 75 people attended and 22 speakers gave talks. Part of the focus was Libby, Montana, where asbestos exposures came from mining amphibole-contaminated vermiculite. The report described what was presented rather than new data of its own. Speakers presented data on amphibole fibers in the bark of trees near the Libby vermiculite mine. They named the health effects of low-level or short-duration exposures, and the toxicity of the Libby amphibole, as gaps in knowledge. At a public forum, the experts generally agreed that there was no "safe" level of asbestos exposure. Dr. Stephen Levin reported that a substantial proportion of 11,768 non-New York Fire Department World Trade Center responders had new-onset or worsened respiratory symptoms. Other talks covered a 25-year follow-up of people exposed to Libby amphibole in an Ohio factory, chromosomal changes in cells exposed to amphiboles, and autoimmunity in mice. Participants felt the conference met its objectives.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Conference summary (meeting report) describing presentations and discussions; no original study data
• Who was studied: Conference held at the University of Montana, Missoula, with approximately 75 attendees (researchers, physicians, health care workers, federal agency representatives) and 22 speakers; the date of the conference is not stated in the text
• Exposure: Asbestos in general, with particular attention to the Libby amphibole from amphibole-contaminated vermiculite mined at Zonolite Mountain near Libby, Montana; the authors note they use "asbestos" to include unregulated amphiboles
• Main results:
  • In the exposure assessment session, speakers presented data on amphibole fibers in tree bark near the Libby vermiculite mine site
  • Speakers identified the health effects of low-level or short-duration exposures, and the toxicity of the Libby amphibole, as gaps in current knowledge
  • At the public "Ask the Experts" forum, the experts generally agreed that there was no safe level of asbestos exposure
  • Dr. Stephen Levin presented an assessment of health effects among 11,768 non-New York Fire Department workers and volunteers who responded to the World Trade Center attack
  • Among those World Trade Center responders, a substantial proportion experienced new-onset or worsened lower and upper respiratory symptoms (as presented by Dr. Levin)
  • Dr. Amy Rohs presented data from a 25-year follow-up of people exposed to the Libby amphibole in an Ohio factory; the report gives no findings from it
  • Presenters reported chromosomal changes in cells exposed to amphiboles, which the report describes as showing gross genetic damage as a possible mechanism needing further analysis
  • Presenters reported the development of autoimmunity in an animal model after exposure to amphibole fibers
  • In a post-conference survey, the participants' consensus was that asbestos research had moved forward in the past three years
• The authors' conclusion: The authors concluded that experience from Libby, vermiculite and asbestos processing sites, and the World Trade Center is giving new insights and tools for future asbestos research. They reported that participants felt both conference objectives (advancing the science toward better prevention or treatment, and building partnerships) were met.

Topics

Medical terms in this study, explained in our Lexicon: Asbestos Exposure, vermiculite.

Related studies

• Conference summary. Directions and needs in asbestos research: new insights — J.C. Pfau, M. Pershouse, et al. (2006)
• Principal components analysis to identify influences on research communication and engagement during an environmental disaster — C.A. Winters, C.F. Moore, et al. (2016)
• Mixtures research at NIEHS: an evolving program — C.V. Rider, D.J. Carlin, et al. (2013)
• Future directions for clinical research with CPT-11 (irinotecan) — D. von Hoff (1996)
• Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018) — L. Wu, I. Dell'Anno, et al. (2019)
• Current Research and Opportunities to Address Environmental Asbestos Exposures — D.J. Carlin, T.C. Larson, et al. (2015)

Browse more research in Journal of Immunotoxicology, or return to medical research.